스벤 리

스벤 리(, 1969년 2월 21일~ )는 한국계 독일 의사이다. 한 때 매스컴을 통해 안과 전문의로 소개되었으나 독일 의대를 졸업하고, 의학석사와 의학박사 학위를 취득하였을 뿐 안과 전문의는 아닌 것으로 밝혀졌다.

개요 
스벤 리는 시력교정수술 중 라섹을 시술하는 레이저 장비(MEL80) 소프트웨어(ASA80) 개발 연구에 참여한 것으로 보인다.. 의학계에 미친 공로를 인정받아 2004년 유럽연합(EU) 은빛훈장을 수여 받았다. ASA라섹은 ASA80 소프트웨어를 이용하여 시술하는 진보된 라섹으로 각막 절삭을 최소화하고, 개인의 안구 형태를 고려한 맞춤식 시력교정이 가능한 수술이다. 2010년에는 미국백내장굴절학회(American Society of Cataract and Refractive Surgery)에서 최고논문상을 수상하였으며, 미국백내장굴절학회(ASCRS)에서 심사위원으로 활동하고 있다.

가족 관계 
스벤 리는 1969년 2월 21일 독일 라인란트팔츠주 마인츠에서 파독간호사의 대부이자 소아과 의사인 이수길 박사의 2남 2녀 중 차남으로 태어났다.

학창 시절 
University of Hannover의 의학박사 시절부터 시력교정수술로 부작용을 앓고 있는 환자에 대한 관심을 가졌고, 치료 기술 개발을 위해 연구에 착수했다. 안구 부작용 치료를 위해서는 비구면인 각막을 구면으로 만들 수 있는 초정밀 레이저 제어 기술이 필요하였고, 해당 분야에 대한 연구를 진행하였다.

ASA라섹의 개발 
2002년 에카르트 슈뢰더 연구팀은 맞춤식 시력교정수술을 가능하게 하는 ASA80 소프트웨어를 개발하였고, 이를 이용한 라섹 수술을 ASA라섹(Advanced Surface Ablation Lasek)이라 명하였다. 2003년 유럽백내장굴절학회(European Society of Cataract and Refractive Surgery)에서 해당 연구에 대해 발표하였다.

유럽 연합(European Union) 은빛 훈장 수여 
개인의 각막 형태에 따라 제어가 가능한 ASA80 소프트웨어와 ASA라섹이라는 진보된 수술법을 개발한 공로를 인정받아 2004년 유럽연합(EU) 은빛훈장을 수여받았다.

세계안과학회 심사위원 활동 
미국백내장굴절학회(ASCRS) 시력교정수술 부문 심사위원으로 활동하며, 전 세계에서 제출되는 관련 논문에 대한 심사를 담당하였다.(2006년, 2009년, 2010년)

기술 연구 개발 
2008년부터 독일 물리학 박사 에카르트 슈뢰더(Eckhard Schroeder), 영국·미국·캐나다 의학박사 댄 라인슈타인(Dan Reinstein), 남아프리카 공화국 의학박사 셀릭 퍼시 아모일즈(Selig Percy Amoils)와 함께 시력교정 기술관련 공동 연구를 진행 중이다.

발표 논문 
  Painfree PRK with fast visual Recovery. ESCRS in Nice, France. 2002
  Cooling techniques during PRK. ESCRS in Nice, France. 2002
  Cooling during PRK. AAO and ISRS in Orlando, USA. 2002
  Painfree PRK with fast visual Recovery. AAO and ISRS in Orlando, USA. 2002
  Painfree PRK with fast Visual Recovery. ASCRS in Philadelphia, USA. 2002
  New Cooling techniques during PRK. ELEOS in Strasbourg, France. 2002
  Advanced Surface Ablation (ASA80) in Excimer Laser Refractive Surgery. ESCRS in Munich, Germany. 2003
  Comparison of First Clinical Results of the Advanced Surface Ablation (ASA80) with the MEL80 vs. MEL70. Zeiss Symposia in Munich, Germany. 2003
  Where is the limit for successful and safe Hyperopic Surface Ablation? Statistical analysis of 237 treated eyes. ESCRS in Barcelona, Spain. 2004
  Where is the limit for successful and safe Myopic Surface Ablation? Statistical analysis of 556 treated eyes. ESCRS in Barcelona, Spain. 2004
  Customized correction of spherical aberrations (Zernike (* 0)) with the Advanced Surface Ablation using the MEL80 (ASA80). ESCRS in Barcelona, Spain. 2004
  Wavefront guided correction of Presbyopia. ESCRS in Barcelona, Spain. 2004
  Comparative Study of Treatment of the Dry Eye Syndrome due to Disturbances of the Tear Film Lipid Layer with Lipid-Containing Tear Substitutes Efficacy of lipid-containing tear substitutes. ESCRS in Paris, France. 2004
  Where is the limit for successful and safe Hyperopic Surface Ablation? Statistical analysis of 237 treated eyes. ESCRS in Paris, France. 2004
  Where is the limit for successful and safe Myopic Surface Ablation? 3-Year-Follow-Up. Statistical analysis of 446 treated eyes. ESCRS in Paris, France. 2004
  Advanced Surface Ablation (ASA80). A new approach to Excimer-Laser-Surface Ablation for the correction of myopia. Statistical comparison with standard PRK. ESCRS in Paris, France. 2004
  Wavefront guided correction of Presbyopia with Advanced Surface Ablation using the MEL 80 (ASA80). 2-9 months follow-up. ESCRS in Paris, France. 2004
  Customized correction of spherical aberrations (Zernike (* 0) with the Advanced Surface Ablation using the MEL80 (ASA80). Zeiss Symposia in Barcelona, Spain. 2004
  Wavefront guided correction of Presbyopia with Advanced Surface Ablation using the MEL 80 (ASA80). 2-9 months follow-up. Zeiss Symposia in San Diego, USA. 2004
  Wavefront guided correction of Presbyopia with Advanced Surface Ablation using the MEL 80 (ASA80). 12 months follow-up. Zeiss Symposia in New Orleans, USA. 2004
  Wavefront guided correction of Presbyopia with Advanced Surface Ablation using the MEL 80 (ASA80). 12 months follow-up. AAO and ISRS in New Orleans, USA. 2004
  Where is the limit for successful and safe Hyperopic Surface Ablation? Statistical analysis of 237 treated eyes. ASCRS in San Diego, USA. 2004
  Where is the limit for successful and safe Myopic Surface Ablation? 3-Year-Follow-Up. Statistical analysis of 446 treated eyes. ASCRS in San Diego, USA. 2004
  Advanced Surface Ablation (ASA80). A new approach to Excimer-Laser-Surface Ablation for the correction of myopia. Statistical comparison with standard PRK. ASCRS in San Diego, USA. 2004
  Wavefront guided correction of Presbyopia with Advanced Surface Ablation using the MEL 80 (ASA80). 2-9 months follow-up. ASCRS in San Diego, USA. 2004
  Panelist in Session 2-J: Keratorefractive Epi-Lasik, Lasik, PRK. ASCRS in San Diego, USA. 2004
  A new therapy concept with a liposome eye spray for the therapy of the "dry eye". First clinical results of a statistical analysis of a long-term study. DOG in Berlin, Germany. 2004
  Where is the limit for successful and safe myopic surface ablation? Statistical Analysis of 556 treated eyes. AAD in Duesseldorf, Germany. 2004
  Wavefront Guided Correction of Presbyopia with ASA80: 2 years follow up. Zeiss Symposia in Chicago, USA. 2005
  Advanced Surface Ablation (ASA80) today. International MEL80 Symposium in Bangkok, Thailand. 2005
  Statistical Analysis of Presbyopia Treatments. International MEL80 Symposium in Bangkok, Thailand. 2005
  Clinical aspects and patient selection for presbyopia treatments. International MEL80 Symposium in Bangkok, Thailand. 2005
  Presbyopia Correction with the MEL *  Statistical Analysis of Clinical Outcomes. AAO and ISRS in Chicago, USA. 2005
  Complications and Treatment of Diabetic Retinopathia. DOG in Berlin, Germany. 2005
  New Advances in Cataract Surgery today. DOG in Berlin, Germany. 2005
  Wavefront guided correction of Contrast Sensitivity, Mesopic Contrast Sensitivity and Presbyopia with Advanced Surface Ablation using the MEL 80 (ASA80®). The 7th Refractive Symposium at the Catholic University in Seoul, Korea. 2005
  Altering Zernike Polynomials to Correct Presbyopia and Quality of Vision Results (ASA80). ASCRS in San Francisco, USA. 2006
  Wavefront Guided Correction of Presbyopia, Contrast Sensitivity and Mesopic Contrast Sensitivity: 2 Year Follow up. ASCRS in San Francisco, USA. 2006
  Panelist in Session 4-C: Wavefront, New Technology. ASCRS in San Francisco, USA. 2006
  Comparative study of the therapy of dry eye syndrome with artificial tear substitutes especially for the treatment of the disturbance of the lipid layer. SOE Congress in Berlin, Germany. 2006
  Comparative study of the therapy of dry eye syndrome with artificial tear substitutes especially for the treatment of the disturbance of the lipid layer. Chinese Academy of Sciences in Shanghai, China. 2006
  Presbyopia Correction with the MEL80 Using ASA80®/ASA Lasek®: Statistical Analysis of clinical outcomes: 3 year follow-up of a Multicenter Study. Turkish Refractive Surgery Symposium in Antalya, Turkey. 2006
  Correction of Presbyopia and Contrast Sensitivity with the MEL 80 Using ASA80®/ASA Lasek®: Statistical Analysis of clinical outcomes. 3 year follow-up of a Multicenter Study. APAO in Singapore, Singapore. 2006
  New aspheric profiles with alternated Zernike Polynomials to improve Presbyopia and Night Vision Problems, esp. in high myopic patients with Advanced Surface Ablation (ASA-Lasek). ESCRS in Stockholm, Sweden. 2007
  Wavefront Guided Correction of Presbyopia, Contrast Sensitivity, Mesopic Contrast Sensitivity with Advanced Surface Ablation (ASA80): 3 year follow-up. ESCRS in Stockholm, Sweden. 2007
  Advanced Surface Ablation using a Spot-Scanning-Excimer Laser (ASA80): Statistical Comparison of results with standard laser profiles and new aspheric ablation profiles with altered Zernike Polynomials. ESCRS in Stockholm, Sweden. 2007
  Creating monovision on the non-dominant eye for the correction of presbyopia by altering Zernike Polynomials. A new approach: 1 year follow-up. ESCRS in Berlin, Germany. 2008
  Treatment of high myopia and hyperopia with wavefront-guided advanced-surface-ablation (ASA-Lasek®). Increasing the depth-of-field with aspheric-shoffiles: 2 year-follow-up. ESCRS in Berlin, Germany. 2008
  Wavefront-Guided Correction of Presbyopia, Contrast Sensitivity, and Mesopic Contrast Sensitivity with Advanced Surface Ablation: Four-Year Follow-up. ASCRS in Berlin, Germany. 2008
  Design of New Aspheric Ablation Profiles with Modified Zernike Polynomials to Improve Presbyopia and Night Vision Problems. ASCRS in Chicago, USA. 2008
  Micromonovision on the non-dominant eye for the correction of presbyopia by altering Zernike Polynomials: new approach - 2 years follow-up. ESCRS in Barcelona, Spain. 2009
  Presbyopia correction with AcrySof ReSTOR, CustomVue monovision, and wavefront-guided monofocal ablation: comparative analysis. ESCRS in Barcelona, Spain. 2009
  Statistical comparison of presbyopia correction with wavefront-guided advanced surface ablation, CustomVue monovision LASIK, and multifocal ReSTOR IOLs. ESCRS in Barcelona, Spain. 2009
  Correction of high refractive errors with wavefront-guided advanced-surface-ablation (ASA-LASEK): increasing the depth-of-field with aspheric-shoffiles- 3 year follow-up. ESCRS in Barcelona, Spain. 2009
  Creating Micromonovision in the Nondominant Eye for the Correction of Presbyopia by Altering Zernike Polynomials: Eighteen-Month Follow-up. ASCRS in San Francisco, USA. 2009
  Treatment of High Myopia and Hyperopia with Wavefront-Guided Advanced Surface Ablation Increasing the Depth-of-Field with Aspheric Shotfiles: Three-Year Follow-up. ASCRS in San Francisco, USA. 2009
  Approaches to Presbyopia Correction: Comparative Analysis of Wavefront-Guided Monofocal Ablation, Multifocal IOLs, and Monovision: Two-Year Results. ASCRS in Boston, USA. 2010
  Wavefront Correction of High Refractive Errors with Aspheric Shotfiles to Increase Depth-of-Field ASA LASEK: Three-Year Results. ASCRS in Boston, USA. 2010

각주 

1969년 출생
살아있는 사람
대한민국의 의사